MPPO_STRHY
ID MPPO_STRHY Reviewed; 341 AA.
AC Q643C1;
DT 16-OCT-2013, integrated into UniProtKB/Swiss-Prot.
DT 25-OCT-2004, sequence version 1.
DT 03-AUG-2022, entry version 42.
DE RecName: Full=Enduracididine beta-hydroxylase;
DE EC=1.14.11.40;
DE AltName: Full=Mannopeptimycin biosynthesis protein O;
GN Name=mppO;
OS Streptomyces hygroscopicus.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces; Streptomyces violaceusniger group.
OX NCBI_TaxID=1912;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=NRRL 30439;
RX PubMed=16723579; DOI=10.1128/aac.01545-05;
RA Magarvey N.A., Haltli B., He M., Greenstein M., Hucul J.A.;
RT "Biosynthetic pathway for mannopeptimycins, lipoglycopeptide antibiotics
RT active against drug-resistant gram-positive pathogens.";
RL Antimicrob. Agents Chemother. 50:2167-2177(2006).
RN [2]
RP FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND DISRUPTION PHENOTYPE.
RC STRAIN=NRRL 30439;
RX PubMed=16298295; DOI=10.1016/j.chembiol.2005.09.013;
RA Haltli B., Tan Y., Magarvey N.A., Wagenaar M., Yin X., Greenstein M.,
RA Hucul J.A., Zabriskie T.M.;
RT "Investigating beta-hydroxyenduracididine formation in the biosynthesis of
RT the mannopeptimycins.";
RL Chem. Biol. 12:1163-1168(2005).
CC -!- FUNCTION: Hydroxylates the beta carbon of free L-enduracididine to
CC produce (3S)-3-hydroxy-L-enduracididine in biosynthesis of the
CC nonproteinogenic amino acid beta-hydroxyenduracididine, a component of
CC antibiotic mannopeptimycin. {ECO:0000269|PubMed:16298295}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2-oxoglutarate + L-enduracididine + O2 = (3S)-3-hydroxy-L-
CC enduracididine + CO2 + succinate; Xref=Rhea:RHEA:36603,
CC ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC ChEBI:CHEBI:30031, ChEBI:CHEBI:73936, ChEBI:CHEBI:73937;
CC EC=1.14.11.40; Evidence={ECO:0000269|PubMed:16298295};
CC -!- COFACTOR:
CC Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000250};
CC Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250};
CC -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000269|PubMed:16298295}.
CC -!- DISRUPTION PHENOTYPE: Cells produce dideoxy-mannopeptimycins.
CC {ECO:0000269|PubMed:16298295}.
CC -!- SIMILARITY: Belongs to the clavaminate synthase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AY735112; AAU34208.1; -; Genomic_DNA.
DR AlphaFoldDB; Q643C1; -.
DR SMR; Q643C1; -.
DR KEGG; ag:AAU34208; -.
DR BRENDA; 1.14.11.40; 6043.
DR GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR Gene3D; 3.60.130.10; -; 1.
DR InterPro; IPR014503; Clavaminate_syn-like.
DR InterPro; IPR042098; TauD-like_sf.
DR InterPro; IPR003819; TauD/TfdA-like.
DR Pfam; PF02668; TauD; 1.
DR PIRSF; PIRSF019543; Clavaminate_syn; 1.
PE 1: Evidence at protein level;
KW Antibiotic biosynthesis; Iron; Metal-binding; Oxidoreductase.
FT CHAIN 1..341
FT /note="Enduracididine beta-hydroxylase"
FT /id="PRO_0000423988"
FT REGION 203..223
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 146
FT /ligand="Fe cation"
FT /ligand_id="ChEBI:CHEBI:24875"
FT /evidence="ECO:0000250"
FT BINDING 148
FT /ligand="Fe cation"
FT /ligand_id="ChEBI:CHEBI:24875"
FT /evidence="ECO:0000250"
FT BINDING 300
FT /ligand="Fe cation"
FT /ligand_id="ChEBI:CHEBI:24875"
FT /evidence="ECO:0000250"
SQ SEQUENCE 341 AA; 38548 MW; 41FD91395A9D5345 CRC64;
MLTLHLQDDD VAAIDAVADE LSRRYDSVES TEFQAESRLY ADELPRRVRR ALHEYRSTEK
SGILVVTGLP VDDSALGATP ADRRHKPVPS TSLRQDIAFY LIANLLGDPI GWATQQDGFI
MHDVYPVQGF EHEQIGWGSE ETLTWHTEDA FHPLRTDYLG LMCLRNPDGV ETTACDIADV
EIDDETRETL SQERFRILPD DAHRIHGKAP GDESARESAL RERSRQRVAS ALESPDPVAV
LFGDRDDPYL RIDPHYMQGV QGETEQRALE TIGAAIDDAM SGVVLSPGDI VFIDNYRVVH
GRKPFRARFD GTDRWLRRLN IARDLRKSRE ARLAATTRVI Y